Sympathomimetic agents in the treatment of shock.
D000136:Acid-Base Equilibrium; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D005500:Follow-Up Studies; D006321:Heart / Q000187:drug effects; D006801:Humans; D009411:Nerve Endings / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D011941:Receptors, Adrenergic; D012039:Regional Blood Flow / Q000187:drug effects; D012769:Shock / Q000188:drug therapy* / Q000503:physiopathology; D012772:Shock, Septic / Q000503:physiopathology; D013566:Sympathomimetics / Q000494:pharmacology / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D011941:Receptors, Adrenergic; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D009638:Norepinephrine